Pacira Therapeutics, Inc.
Records under this name other than the patents Pacira Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 14 patents it holds.
Showing 1 to 3 of 3 · Back to Pacira Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,480,677 | Enantiomers of Spiro-Oxindole Compounds and Their Uses as Therapeutic Agents Lapsed on the fee record Ended Nov 1, 2024 · Low confidence | Lapsed on the fee record | Ended Nov 1, 2024 | Low confidence |
| US 9,260,446 | Synthetic Methods for Spiro-Oxindole Compounds Lapsed on the fee record Ended Feb 16, 2024 · Medium confidence | Lapsed on the fee record | Ended Feb 16, 2024 | Medium confidence |
| US 10,513,526 | Solid State Forms of Spiro-Oxindole Compounds Lapsed on the fee record Ended Dec 24, 2023 · High confidence | Lapsed on the fee record | Ended Dec 24, 2023 | High confidence |